Boston Scientific reported quarterly EPS of $0.80, matching the Zacks Consensus Estimate and up from $0.75 a year ago. The result is a modest year-over-year improvement but contains no surprise versus expectations, making the release largely neutral for the stock.
Boston Scientific reported quarterly EPS of $0.80, matching the Zacks Consensus Estimate and up from $0.75 a year ago. The result is a modest year-over-year improvement but contains no surprise versus expectations, making the release largely neutral for the stock.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
neutral
Sentiment Score
0.12
Ticker Sentiment
